Skip to main content
Top
Published in: Journal of Cardiovascular Translational Research 6/2015

01-08-2015

Percutaneous Fluoroscopic-Guided Endomyocardial Delivery in an Experimental Model of Left Ventricular Assist Device Support

Authors: Magnus Dalén, Atta Behfar, Andre Terzic, Petter Schiller, Aymeric Seron, Warren Sherman, Agneta Månsson-Broberg, Karl-Henrik Grinnemo

Published in: Journal of Cardiovascular Translational Research | Issue 6/2015

Login to get access

Abstract

Endomyocardial delivery in the setting of active left ventricular assist device (LVAD) support has rarely been studied. The objective was to establish a protocol for endomyocardial injections during LVAD support without compromising mechanical circulation. LVAD implantation was performed in four pigs. A curved needle catheter was percutaneously inserted into the right carotid artery and positioned into the left ventricle under fluoroscopic guidance. In the setting of increasing LVAD flows (2.3–3.1 l/min), percutaneous methylene blue dye administration into the myocardium proceeded without complications in all pigs. Transection of excised hearts revealed an anterior, lateral, inferior, and septal wall distribution of methylene blue documenting injections in all four regions of the left ventricle. Ex vivo, the catheter could be maneuvered close to the LVAD inflow cannula despite augmentation of LVAD flow up to 5 l/min. Endomyocardial injections during LVAD support was found to be feasible and safe with the curved needle catheter.
Appendix
Available only for authorised users
Literature
2.
go back to reference Redfield, M. M., Jacobsen, S. J., Burnett, J. C., Jr., et al. (2003). Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA, 289, 194–202.CrossRefPubMed Redfield, M. M., Jacobsen, S. J., Burnett, J. C., Jr., et al. (2003). Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA, 289, 194–202.CrossRefPubMed
3.
go back to reference Slaughter, M. S., Rogers, J. G., Milano, C. A., Russel, S. D., Conte, J. V., Feldman, D., et al. (2009). Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl Med, 361, 2241–2251.CrossRef Slaughter, M. S., Rogers, J. G., Milano, C. A., Russel, S. D., Conte, J. V., Feldman, D., et al. (2009). Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl Med, 361, 2241–2251.CrossRef
4.
go back to reference Birks, E. J. (2013). Molecular changes after left ventricular assist device support for heart failure. Circulation Research, 113, 777–791.CrossRefPubMed Birks, E. J. (2013). Molecular changes after left ventricular assist device support for heart failure. Circulation Research, 113, 777–791.CrossRefPubMed
5.
go back to reference Hall, J. L., Fermin, D. R., Birks, E. J., Barton, P. J., Slaughter, M., & Eckman, P. (2011). Clinical, molecular, and genomic changes in response to a left ventricular assist device. Journal of the American College of Cardiology, 57, 641–652.CrossRefPubMedCentralPubMed Hall, J. L., Fermin, D. R., Birks, E. J., Barton, P. J., Slaughter, M., & Eckman, P. (2011). Clinical, molecular, and genomic changes in response to a left ventricular assist device. Journal of the American College of Cardiology, 57, 641–652.CrossRefPubMedCentralPubMed
6.
go back to reference Behfar, A., Crespo-Diaz, R., Terzic, A., & Gersh, B. J. (2014). Cell therapy for cardiac repair—lessons from clinical trials. Nature Reviews Cardiology, 11, 232–246.CrossRefPubMed Behfar, A., Crespo-Diaz, R., Terzic, A., & Gersh, B. J. (2014). Cell therapy for cardiac repair—lessons from clinical trials. Nature Reviews Cardiology, 11, 232–246.CrossRefPubMed
7.
go back to reference Ibrahim, M., & Yacoub, M. H. (2014). Bridge to recovery and weaning protocols. Heart Failure Clinics, 10, S47–S55.CrossRefPubMed Ibrahim, M., & Yacoub, M. H. (2014). Bridge to recovery and weaning protocols. Heart Failure Clinics, 10, S47–S55.CrossRefPubMed
8.
go back to reference Anastasiadis, K., Antonitsis, P., Argiriadou, H., Koliakos, G., Doumas, A., Khayat, A., et al. (2011). Hybrid approach of ventricular assist device and autologous bone marrow stem cells implantation in end-stage ischemic heart failure enhances myocardial reperfusion. Journal of Translational Medicine, 9, 12.CrossRefPubMedCentralPubMed Anastasiadis, K., Antonitsis, P., Argiriadou, H., Koliakos, G., Doumas, A., Khayat, A., et al. (2011). Hybrid approach of ventricular assist device and autologous bone marrow stem cells implantation in end-stage ischemic heart failure enhances myocardial reperfusion. Journal of Translational Medicine, 9, 12.CrossRefPubMedCentralPubMed
9.
go back to reference Ascheim, D. D., Gelijns, A. C., Goldstein, D., Moye, L. A., Smedira, N., Lee, S., et al. (2014). Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices. Circulation, 129, 2287–2296.CrossRefPubMedCentralPubMed Ascheim, D. D., Gelijns, A. C., Goldstein, D., Moye, L. A., Smedira, N., Lee, S., et al. (2014). Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices. Circulation, 129, 2287–2296.CrossRefPubMedCentralPubMed
10.
go back to reference Zheng, Y., Sampaio, L. C., Li, K., Silva, G. V., Cabreira-Hansen, M., Vela, D., et al. (2013). Safety and feasibility of mapping and stem cell delivery in the presence of an implanted left ventricular assist device: a preclinical investigation in sheep. Texas Heart Institute Journal, 40, 229–234.PubMedCentralPubMed Zheng, Y., Sampaio, L. C., Li, K., Silva, G. V., Cabreira-Hansen, M., Vela, D., et al. (2013). Safety and feasibility of mapping and stem cell delivery in the presence of an implanted left ventricular assist device: a preclinical investigation in sheep. Texas Heart Institute Journal, 40, 229–234.PubMedCentralPubMed
11.
go back to reference Behfar, A., Latere, J. P., Bartunek, J., Homsy, C., Daro, D., Crespo-Diaz, R. J., et al. (2013). Optimized delivery system achieves enhanced endomyocardial stem cell retention. Circulation. Cardiovascular Interventions, 6, 708–710.CrossRef Behfar, A., Latere, J. P., Bartunek, J., Homsy, C., Daro, D., Crespo-Diaz, R. J., et al. (2013). Optimized delivery system achieves enhanced endomyocardial stem cell retention. Circulation. Cardiovascular Interventions, 6, 708–710.CrossRef
12.
go back to reference Vikholm, P., Schiller, P., Johansson, J., & Hellgren, L. (2014). Cavoaortic shunt improves hemodynamics with preserved oxygen delivery in experimental right ventricular failure during left ventricular assist device therapy. Journal of Thoracic and Cardiovascular Surgery, 147, 625–631.CrossRefPubMed Vikholm, P., Schiller, P., Johansson, J., & Hellgren, L. (2014). Cavoaortic shunt improves hemodynamics with preserved oxygen delivery in experimental right ventricular failure during left ventricular assist device therapy. Journal of Thoracic and Cardiovascular Surgery, 147, 625–631.CrossRefPubMed
13.
go back to reference Nakamuta, J. S., Danoviz, M. E., Marques, F. L., dos Santos, L., Becker, C., Gonçalves, G. A., et al. (2009). Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold. PLoS One, 4, e6005.CrossRefPubMedCentralPubMed Nakamuta, J. S., Danoviz, M. E., Marques, F. L., dos Santos, L., Becker, C., Gonçalves, G. A., et al. (2009). Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold. PLoS One, 4, e6005.CrossRefPubMedCentralPubMed
14.
go back to reference Telukuntla, K. S., Suncion, V. Y., Schulman, I. H., & Hare, J. M. (2013). The advancing field of cell-based therapy: insights and lessons from clinical trials. J Am Heart Assoc, 2, e000338.CrossRefPubMedCentralPubMed Telukuntla, K. S., Suncion, V. Y., Schulman, I. H., & Hare, J. M. (2013). The advancing field of cell-based therapy: insights and lessons from clinical trials. J Am Heart Assoc, 2, e000338.CrossRefPubMedCentralPubMed
Metadata
Title
Percutaneous Fluoroscopic-Guided Endomyocardial Delivery in an Experimental Model of Left Ventricular Assist Device Support
Authors
Magnus Dalén
Atta Behfar
Andre Terzic
Petter Schiller
Aymeric Seron
Warren Sherman
Agneta Månsson-Broberg
Karl-Henrik Grinnemo
Publication date
01-08-2015
Publisher
Springer US
Published in
Journal of Cardiovascular Translational Research / Issue 6/2015
Print ISSN: 1937-5387
Electronic ISSN: 1937-5395
DOI
https://doi.org/10.1007/s12265-015-9642-4

Other articles of this Issue 6/2015

Journal of Cardiovascular Translational Research 6/2015 Go to the issue